Grand Rapids Clinical Oncology Program — Grand Rapids, Michigan

Grand Rapids Clinical Oncology Program is a clinical research site located in Grand Rapids, Michigan, United States 49503.

Crixeo Clinical Trials Trust Score: 27/100 (FAILING). This profile has not yet been claimed by the site owner.

Grand Rapids Clinical Oncology Program has participated in 57 clinical trials with 1 currently active.

Therapeutic areas: Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.

Sponsors: ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI), SCRI Development Innovations, LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Grand Rapids

Browse all research sites in Michigan · View every site in Grand Rapids

Sponsor Feasibility Report

Trust Score: 27/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Grand Rapids Clinical Oncology Program?

Grand Rapids Clinical Oncology Program has a Crixeo Trust Score of 27/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Grand Rapids Clinical Oncology Program conducted?

Grand Rapids Clinical Oncology Program has 57 clinical trials on record, with 1 currently active. Their work covers Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.

Is Grand Rapids Clinical Oncology Program accredited by Crixeo Clinical Trials?

Grand Rapids Clinical Oncology Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Grand Rapids Clinical Oncology Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.